We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-9.94%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.23B
AUM Growth
-$302M
Cap. Flow
+$232M
Cap. Flow %
7.17%
Top 10 Hldgs %
15.77%
Holding
277
New
41
Increased
95
Reduced
109
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 33.24%
2 Healthcare 17.69%
3 Industrials 11.31%
4 Consumer Discretionary 8.04%
5 Financials 5.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTC icon
76
PTC
PTC
$16B
$14.7M 0.45%
462,446
-189,800
-29% -$6.79M
MSCC
77
DELISTED
Microsemi Corp
MSCC
$14.7M 0.45%
447,000
-77,000
-15% -$2.51M
CVT
78
DELISTED
CVENT, INC.
CVT
$14.7M 0.45%
435,537
+145,508
+50% +$4.4M
ENTA icon
79
Enanta Pharmaceuticals
ENTA
$400M
$14.6M 0.45%
403,430
+168,300
+72% +$7.23M
GWR
80
DELISTED
Genesee & Wyoming Inc.
GWR
$14.4M 0.45%
244,360
-24,400
-9% -$1.68M
GWRE icon
81
Guidewire Software
GWRE
$14.2B
$14.4M 0.45%
+274,264
New +$15.2M
CCOI icon
82
Cogent Communications
CCOI
$508M
$14.1M 0.44%
+517,589
New +$15.3M
HA
83
DELISTED
Hawaiian Holdings, Inc.
HA
$13.9M 0.43%
562,752
-19,600
-3% -$467K
IPHI
84
DELISTED
INPHI CORPORATION
IPHI
$13.7M 0.43%
571,651
-66,200
-10% -$1.52M
SPNC
85
DELISTED
Spectranetics Corp
SPNC
$13.5M 0.42%
1,147,918
+58,218
+5% +$1.04M
INGN icon
86
Inogen
INGN
$164M
$13.5M 0.42%
+278,456
New +$13.2M
BYD icon
87
Boyd Gaming
BYD
$6.06B
$13.3M 0.41%
813,598
+195,898
+32% +$3.24M
SAGE
88
DELISTED
Sage Therapeutics
SAGE
$13.2M 0.41%
311,265
+36,600
+13% +$2.26M
EPAM icon
89
EPAM Systems
EPAM
$5.03B
$13.1M 0.41%
176,100
-28,900
-14% -$2.09M
CEMP
90
DELISTED
Cempra, Inc.
CEMP
$13.1M 0.41%
+470,800
New +$17.5M
SFE
91
DELISTED
Safeguard Scientifics, Inc.
SFE
$12.6M 0.39%
810,913
-65,646
-7% -$1.18M
TYPE
92
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$12.5M 0.39%
574,027
+125,016
+28% +$2.87M
MPWR icon
93
Monolithic Power Systems
MPWR
$68.9B
$12.5M 0.39%
244,236
-28,000
-10% -$1.39M
EBIX
94
DELISTED
Ebix Inc
EBIX
$12.5M 0.39%
498,832
+261,807
+110% +$7.76M
CPHD
95
DELISTED
Cepheid Inc
CPHD
$12.4M 0.38%
+274,300
New +$14.6M
QLYS icon
96
Qualys
QLYS
$6.35B
$12.3M 0.38%
432,490
+29,800
+7% +$1,000K
XLRN
97
DELISTED
Acceleron Pharma
XLRN
$12.2M 0.38%
490,436
+21,400
+5% +$643K
EVH icon
98
Evolent Health
EVH
$447M
$12M 0.37%
753,571
+90,914
+14% +$1.77M
VASC
99
DELISTED
Vascular Solutions Inc
VASC
$12M 0.37%
370,507
-80,177
-18% -$2.87M
ATRC icon
100
AtriCure
ATRC
$2.11B
$11.7M 0.36%
536,007
-1,087
-0.2% -$27.2K

Similar funds

Granahan Investment Management's Q3 2015 Portfolio in Review

As of Q3 2015, Granahan Investment Management held 277 positions worth $3.23B, down 8.6% from $3.53B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granahan Investment Management deployed $232M of net new capital in Q3 2015, opening 41 new positions and adding to 95 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 250,380 shares worth $33.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Bruker, an estimated $11.2M trimmed.

  • Granahan Investment Management's largest Q3 2015 buy was iShares Russell 2000 Growth ETF: 250,380 shares worth $33.5M.
  • Granahan Investment Management added most to DEMANDWARE INC COM STK (DE) in Q3 2015, an estimated $15.5M increase.
  • Granahan Investment Management's biggest Q3 2015 reduction was Bruker, cutting an estimated $11.2M.
  • Granahan Investment Management fully exited Vertex Pharmaceuticals in Q3 2015, selling an estimated $24M.
  • Granahan Investment Management's ten largest holdings make up 16% of its $3.23B portfolio in Q3 2015.
  • Granahan Investment Management opened 41 new positions and closed 22 in Q3 2015.
  • Granahan Investment Management's portfolio value fell 8.6% quarter-over-quarter to $3.23B.

Based on Granahan Investment Management's 13F filing for Q3 2015, filed 12 Nov 2015.